PURINETHOL 50 mg Oral Tablet
RxNorm 206788
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 206788 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: PURINETHOL 50 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Mercaptopurine 50 mg Oral Tablet [Purinethol]
(Atom ID: 3501716)
PSN
Prescribable Name (PSN):
PURINETHOL 50 mg Oral Tablet
(Atom ID: 6364567)
SY
Synonym (SY):
Purinethol 50 mg Oral Tablet
(Atom ID: 1911339)
Patient Education
Mercaptopurine
Mercaptopurine is used alone or with other chemotherapy drugs to treat acute lymphocytic leukemia (ALL; also called acute lymphoblastic leukemia and acute lymphatic leukemia; a type of cancer that begins in the white blood cells). Mercaptopurine is in a class of medications called purine antagonists. It works by stopping the growth of cancer cells.
[Learn More]
* Please review the disclaimer below.